Immediate Discharge and Home Treatment With Rivaroxaban of Low‐risk Venous Thromboembolism Diagnosed in Two U.S. Emergency Departments: A One‐year Preplanned Analysis

By  

ACADEMIC EMERGENCY MEDICINE, Vol. 22, Iss. 7, 2015-07 ,pp. : 788-795

John Wiley & Sons Inc

Access to resources Recommend Favorite

Does Low-Molecular-Weight Heparin Reduce the Costs of Venous Thromboembolism Treatment?

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 30, Iss. 2, 2004-11 ,pp. : 136-140

Karger

Access to resources Recommend Favorite

Use of Prestudy Heparin Did Not Influence the Efficacy and Safety of Rivaroxaban in Patients Treated for Symptomatic Venous Thromboem‐bolism in the EINSTEIN DVT and EINSTEIN PE Studies

By  

ACADEMIC EMERGENCY MEDICINE, Vol. 22, Iss. 2, 2015-02 ,pp. : 142-149

John Wiley & Sons Inc

Access to resources Recommend Favorite

Home Treatment of Venous Thromboembolism with Low-Molecular-Weight Heparins

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 3, 2004-11 ,pp. : 83-84

Karger

Access to resources Recommend Favorite

Unfractionated Heparin and Low-Molecular-Weight Heparin for the Initial Treatment of Acute Venous Thromboembolism

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 3, 2004-11 ,pp. : 85-90

Karger

Access to resources Recommend Favorite